These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 20805313)

  • 1. Do gliadin and tissue transglutaminase mediate PPAR downregulation in intestinal cells of patients with coeliac disease?
    De Re V; Simula MP; Notarpietro A; Canzonieri V; Cannizzaro R; Toffoli G
    Gut; 2010 Dec; 59(12):1730-1. PubMed ID: 20805313
    [No Abstract]   [Full Text] [Related]  

  • 2. Lysosomal accumulation of gliadin p31-43 peptide induces oxidative stress and tissue transglutaminase-mediated PPARgamma downregulation in intestinal epithelial cells and coeliac mucosa.
    Luciani A; Villella VR; Vasaturo A; Giardino I; Pettoello-Mantovani M; Guido S; Cexus ON; Peake N; Londei M; Quaratino S; Maiuri L
    Gut; 2010 Mar; 59(3):311-9. PubMed ID: 19951908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of human-tissue transglutaminase IgG and anti-gliadin IgG antibodies in the diagnosis of coeliac disease in patients with selective immunoglobulin A deficiency.
    Lenhardt A; Plebani A; Marchetti F; Gerarduzzi T; Not T; Meini A; Villanacci V; Martelossi S; Ventura A
    Dig Liver Dis; 2004 Nov; 36(11):730-4. PubMed ID: 15571003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross linking to tissue transglutaminase and collagen favours gliadin toxicity in coeliac disease.
    Dieterich W; Esslinger B; Trapp D; Hahn E; Huff T; Seilmeier W; Wieser H; Schuppan D
    Gut; 2006 Apr; 55(4):478-84. PubMed ID: 16188922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gliadin is a good substrate of several transglutaminases: possible implication in the pathogenesis of coeliac disease.
    Skovbjerg H; Norén O; Anthonsen D; Moller J; Sjöström H
    Scand J Gastroenterol; 2002 Jul; 37(7):812-7. PubMed ID: 12190095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A quantitative analysis of transglutaminase 2-mediated deamidation of gluten peptides: implications for the T-cell response in celiac disease.
    Dørum S; Qiao SW; Sollid LM; Fleckenstein B
    J Proteome Res; 2009 Apr; 8(4):1748-55. PubMed ID: 19239248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and enzymatic activity of small intestinal tissue transglutaminase in celiac disease.
    Esposito C; Paparo F; Caputo I; Porta R; Salvati VM; Mazzarella G; Auricchio S; Troncone R
    Am J Gastroenterol; 2003 Aug; 98(8):1813-20. PubMed ID: 12907337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transamidation of wheat flour inhibits the response to gliadin of intestinal T cells in celiac disease.
    Gianfrani C; Siciliano RA; Facchiano AM; Camarca A; Mazzeo MF; Costantini S; Salvati VM; Maurano F; Mazzarella G; Iaquinto G; Bergamo P; Rossi M
    Gastroenterology; 2007 Sep; 133(3):780-9. PubMed ID: 17678925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unexpected role of surface transglutaminase type II in celiac disease.
    Maiuri L; Ciacci C; Ricciardelli I; Vacca L; Raia V; Rispo A; Griffin M; Issekutz T; Quaratino S; Londei M
    Gastroenterology; 2005 Nov; 129(5):1400-13. PubMed ID: 16285941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Determination of anti-transglutaminase antibodies in the diagnosis of coeliac disease in children: results of a five year prospective study].
    Laadhar L; Bouaziz N; Ben Ayed M; Chaabouni M; Boudawara T; Hachicha M; Jliri R; Triki A; Masmoudi H
    Ann Biol Clin (Paris); 2004; 62(4):431-6. PubMed ID: 15297237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring of in vitro deamidation of gliadin peptic fragment by mass spectrometry may reflect one of the molecular mechanisms taking place in celiac disease development.
    Novák P; Man P; Tucková L; Tlaskalová-Hogenová H; Bezouska K; Havlícek V
    J Mass Spectrom; 2002 May; 37(5):507-11. PubMed ID: 12112756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue transglutaminase antibodies in celiac disease, comparison of an enzyme linked immunosorbent assay and a dot blot assay.
    Mankaï A; Sakly W; Landolsi H; Gueddah L; Sriha B; Ayadi A; Sfar MT; Skandrani K; Harbi A; Essoussi AS; Korbi S; Fabien N; Jeddi M; Ghedira I
    Pathol Biol (Paris); 2005 May; 53(4):204-9. PubMed ID: 15850953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PPAR signaling pathway and cancer-related proteins are involved in celiac disease-associated tissue damage.
    Simula MP; Cannizzaro R; Canzonieri V; Pavan A; Maiero S; Toffoli G; De Re V
    Mol Med; 2010; 16(5-6):199-209. PubMed ID: 20454521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resurrection of gliadin antibodies in coeliac disease. Deamidated gliadin peptide antibody test provides additional diagnostic benefit.
    Kaukinen K; Collin P; Laurila K; Kaartinen T; Partanen J; Mäki M
    Scand J Gastroenterol; 2007 Dec; 42(12):1428-33. PubMed ID: 17852878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anti-deamidated gliadin peptides antibodies and coeliac disease: state of art and analysis of false-positive results from five assays].
    Lutteri L; Sagot C; Chapelle JP
    Ann Biol Clin (Paris); 2010; 68(2):149-56. PubMed ID: 20348047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathways of gliadin transport in celiac disease.
    Heyman M; Menard S
    Ann N Y Acad Sci; 2009 May; 1165():274-8. PubMed ID: 19538316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transglutaminase 2 in the enterocytes is coeliac specific and gluten dependent.
    Biagi F; Campanella J; Laforenza U; Gastaldi G; Tritto S; Grazioli M; Villanacci V; Corazza GR
    Dig Liver Dis; 2006 Sep; 38(9):652-8. PubMed ID: 16916632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A role for tissue transglutaminase in alpha-gliadin peptide cytotoxicity.
    Sakly W; Thomas V; Quash G; El Alaoui S
    Clin Exp Immunol; 2006 Dec; 146(3):550-8. PubMed ID: 17100777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cells from celiac disease lesions recognize gliadin epitopes deamidated in situ by endogenous tissue transglutaminase.
    Molberg O; McAdam S; Lundin KE; Kristiansen C; Arentz-Hansen H; Kett K; Sollid LM
    Eur J Immunol; 2001 May; 31(5):1317-23. PubMed ID: 11465088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transglutaminase and the pathogenesis of coeliac disease.
    Stenberg P; Roth EB; Sjöberg K
    Eur J Intern Med; 2008 Mar; 19(2):83-91. PubMed ID: 18249302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.